Bronium

Bronium may be available in the countries listed below.

Ingredient matches for Bronium

Bromazepam

Bromazepam is reported as an ingredient of Bronium in the following countries:

• Bangladesh

International Drug Name Search

Vincristine Teva

Vincristine Teva may be available in the countries listed below.

Ingredient matches for Vincristine Teva

Vincristine

Vincristine sulfate (a derivative of Vincristine) is reported as an ingredient of Vincristine Teva in the following countries:

• France


• Latvia


• Lithuania


• Luxembourg


• Poland


• Turkey

International Drug Name Search

BiCNU

Generic Name: carmustine (kar MUS teen)

Brand Names: BiCNU, Gliadel

What is BiCNU (carmustine)?

Carmustine is a cancer medication that interferes with the growth and spread of cancer cells in the body.

Carmustine is used to treat brain tumors, Hodgkin's disease, multiple myeloma, and non-Hodgkin's lymphoma.

Carmustine is sometimes given with other cancer medications.

Carmustine may also be used for other purposes not listed in this medication guide.

What is the most important information I should know about BiCNU (carmustine)?

Do not use carmustine if you are pregnant. It could harm the unborn baby. You should not use this medication if you are allergic to carmustine.

Before receiving carmustine, tell your doctor if you have bone marrow suppression, liver or kidney disease, or a history of lung or breathing problems.

Carmustine is usually given once every 6 weeks. You may be given either a single injection or multiple injections over a 2-day period. Follow your doctor's dosing instructions very carefully.

Carmustine can cause nausea and vomiting that may last up to 6 hours after your injection. Carmustine can lower blood cells that help your body fight infections. Your blood will need to be tested weekly for at least 6 weeks after you receive a dose of carmustine. Your kidneys, liver, and lung function may also need to be tested. Do not miss any follow-up visits to your doctor.

What should I discuss with my healthcare provider before receiving BiCNU (carmustine)?

You should not receive this medication if you are allergic to it.

To make sure you can safely receive carmustine, tell your doctor if you have any of these other conditions:

• 
  

  bone marrow suppression;

  
  


• liver disease;


• kidney disease; or


• 
  

  a history of lung or breathing problems.

  
  

FDA pregnancy category D. Do not use carmustine if you are pregnant. It could harm the unborn baby. Use effective birth control, and tell your doctor if you become pregnant during treatment. It is not known whether carmustine passes into breast milk or if it could harm a nursing baby. You should not breast-feed while you are being treated with carmustine.

How is carmustine given?

Carmustine is injected into a vein through an IV. You will receive this injection in a clinic or hospital setting. Carmustine must be given slowly, and the IV infusion can take at least 2 hours to complete.

Carmustine is usually given once every 6 weeks. You may be given either a single injection or multiple injections over a 2-day period. Follow your doctor's dosing instructions very carefully.

Tell your caregivers if you feel any burning or pain around the IV needle when carmustine is injected. Carmustine can cause nausea and vomiting that may last up to 6 hours after your injection. You may be given anti-nausea medications to help prevent these side effects.

Carmustine can lower blood cells that help your body fight infections. Your blood will need to be tested often. Your cancer treatments may be delayed based on the results of these tests. Visit your doctor regularly.

To be sure your blood cells do not get too low, your blood will need to be tested weekly for at least 6 weeks after you receive a dose of carmustine. This medication can have long-lasting effects on your body. Your kidneys, liver, and lung function may also need to be tested. Do not miss any follow-up visits to your doctor for blood or urine tests.

What happens if I miss a dose?

Call your doctor for instructions if you miss an appointment for your carmustine injection.

What happens if I overdose?

Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.

Overdose symptoms may include severe forms of the serious side effects listed in this medication guide.

What should I avoid while receiving BiCNU (carmustine)?

Avoid being near people who are sick or have infections. Tell your doctor at once if you develop signs of infection.

BiCNU (carmustine) side effects

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat. Call your doctor at once if you have a serious side effect such as:

• 
  

  new or worsening cough, fever, trouble breathing;

  
  


• 
  

  feeling short of breath on exertion;

  
  


• 
  

  chest discomfort, dry cough or hack;

  
  


• 
  

  feeling weak or tired, loss of appetite, rapid weight loss;

  
  


• 
  

  fever, chills, body aches, flu symptoms, sores in your mouth and throat;

  
  


• 
  

  easy bruising, unusual bleeding (nose, mouth, vagina, or rectum), purple or red pinpoint spots under your skin;

  
  


• 
  

  pale skin, feeling light-headed, rapid heart rate, trouble concentrating;

  
  


• 
  

  urinating less than usual or not at all;

  
  


• 
  

  drowsiness, confusion, mood changes, increased thirst, swelling, weight gain, feeling short of breath;

  
  


• 
  

  severe burning, irritation, or skin changes where the injection was given; or

  
  


• 
  

  redness of your eyes or skin and severe warmth or tingling under your skin (within 2 to 4 hours after your carmustine injection).

  
  

Less serious side effects may include:

• 
  

  nausea, vomiting;

  
  


• 
  

  headache; or

  
  


• 
  

  mild pain, swelling, redness, or darkened skin color where the injection was given.

  
  

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

What other drugs will affect BiCNU (carmustine)?

Tell your doctor about all other medications you use, especially cimetidine (Tagamet).

There may be other drugs that can interact with carmustine. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.

More BiCNU resources

• BiCNU Side Effects (in more detail)
• BiCNU Use in Pregnancy & Breastfeeding
• BiCNU Drug Interactions
• BiCNU Support Group
• 0 Reviews for BiCNU - Add your own review/rating

• BiCNU MedFacts Consumer Leaflet (Wolters Kluwer)


• BiCNU Prescribing Information (FDA)


• Carmustine Monograph (AHFS DI)


• Carmustine Professional Patient Advice (Wolters Kluwer)


• carmustine Implantation Advanced Consumer (Micromedex) - Includes Dosage Information


• Bicnu Advanced Consumer (Micromedex) - Includes Dosage Information


• Gliadel Prescribing Information (FDA)


• Gliadel Implant Wafer MedFacts Consumer Leaflet (Wolters Kluwer)

Compare BiCNU with other medications

• Brain Tumor
• Glioblastoma Multiforme
• Hodgkin's Lymphoma
• Malignant Glioma
• Multiple Myeloma
• Non-Hodgkin's Lymphoma

Where can I get more information?

• Your doctor or pharmacist can provide more information about carmustine.

See also: BiCNU side effects (in more detail)

Begalin

Begalin may be available in the countries listed below.

Ingredient matches for Begalin

Sultamicillin

Sultamicillin tosilate (a derivative of Sultamicillin) is reported as an ingredient of Begalin in the following countries:

• Greece

International Drug Name Search

Hasanglib 5

Hasanglib 5 may be available in the countries listed below.

Ingredient matches for Hasanglib 5

Glibenclamide

Glibenclamide is reported as an ingredient of Hasanglib 5 in the following countries:

• Vietnam

International Drug Name Search

Hexa-Blok

Hexa-Blok may be available in the countries listed below.

Ingredient matches for Hexa-Blok

Atenolol

Atenolol is reported as an ingredient of Hexa-Blok in the following countries:

• South Africa

International Drug Name Search

Fenotec

Fenotec may be available in the countries listed below.

Ingredient matches for Fenotec

Fenoterol

Fenoterol hydrobromide (a derivative of Fenoterol) is reported as an ingredient of Fenotec in the following countries:

• Peru

International Drug Name Search